Circulating T Cells Exhibit Different TIM3/Galectin-9 Expression in Patients with Obesity and Obesity-Related Diabetes

Figure 1

TIM3 and galectin-9 expression in healthy controls, obesity, and obesity-related diabetes patients. (a) The expression level of TIM3 was detected by the flow cytometry of CD3⁺, CD4⁺, and CD8⁺ T cells from the HC, OB, and OD groups. (b) Percentages of CD3⁺TIM3⁺, CD4⁺TIM3⁺, and CD8⁺TIM3⁺ cells in the PBMC samples of patients from the HC, OB, and OD groups. (c) Expression of galectin-9 in the plasma of the HC, OB, and OD groups.

(a)

(b)

(c)